Scarica l'app Stockscreener
20.67
2.48%
0.50
Dopo l'orario di chiusura:
20.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$20.17
Aprire:
$20.41
Volume 24 ore:
613.20K
Relative Volume:
1.67
Capitalizzazione di mercato:
$995.22M
Reddito:
$151.91M
Utile/perdita netta:
$-46.03M
Rapporto P/E:
-20.47
EPS:
-1.01
Flusso di cassa netto:
$5.65M
1 W Prestazione:
-8.01%
1M Prestazione:
-8.82%
6M Prestazione:
-20.10%
1 anno Prestazione:
-16.79%
Intervallo 1D:
$20.20
$21.01
Intervallo di 1 settimana:
$19.55
$25.25
Portata 52W:
$19.10
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
20.67 | 971.15M | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
BLFS SEC FilingsBiolife Solutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioLife Solutions (BLFS) -10%: Stock Drops on 'Sell the News' Reaction to Strong Guidance - Trefis
BioLife Solutions (NASDAQ:BLFS) Stock Price Down 11.2%Time to Sell? - MarketBeat
BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention - DirectorsTalk Interviews
BioLife Solutions, Inc. $BLFS Shares Sold by Royce & Associates LP - MarketBeat
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation - TipRanks
BioLife Solutions issues investor presentation highlighting FY2025 results and 2026 guidance - TradingView
BioLife Solutions (BLFS) details 2025 surge and 2026 profit outlook - Stock Titan
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade - sharewise.com
Does BioLife’s 2026 Profitability Guidance and Media Strength Change The Bull Case For BLFS? - simplywall.st
Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors? - Yahoo Finance
BLFS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BLFS PE Ratio & Valuation, Is BLFS Overvalued - Intellectia AI
BioLife Solutions (NASDAQ:BLFS) Raised to Buy at Wall Street Zen - MarketBeat
BioLife Solutions (NASDAQ:BLFS) Shares Gap UpWhat's Next? - MarketBeat
Can BioLife Solutions Capitalize On The Explosive Growth Of The Cell And Gene Therapy Market? - RTTNews
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript - Insider Monkey
BioLife Solutions (BLFS) Q4 Profitability Glimpse Tests Bullish Margin Narratives - Sahm
Beyond the Balance Sheet: What SWOT Reveals About BioLife Soluti - GuruFocus
BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: BioLife Solutions Q4 2025 earnings beat expectations - Investing.com Nigeria
BioLife Solutions Inc reports results for the quarter ended September 30Earnings Summary - TradingView
BioLife Solutions (BLFS) director receives 8,170-share stock grant - Stock Titan
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates - Nasdaq
BioLife Solutions (NASDAQ: BLFS) exec reports stock grant and tax withholding - Stock Titan
BioLife Solutions (NASDAQ: BLFS) CMO gets stock awards and tax withholding - Stock Titan
BioLife Solutions (BLFS) director awarded 8,170 restricted shares - Stock Titan
BioLife Solutions (BLFS) CFO receives 2026 stock grants - Stock Titan
Restricted stock grant to BioLife Solutions (BLFS) director Ellingson - Stock Titan
New stock awards and tax share withholdings for BioLife (BLFS) CEO - Stock Titan
BioLife Solutions (BLFS) EVP granted stock awards and withholds shares for tax - Stock Titan
BioLife Solutions (BLFS) HR chief awarded 23,548 shares - Stock Titan
BioLife Solutions (BLFS) CTO granted 24,116 restricted shares for 2026 pay - Stock Titan
[Form 4] BIOLIFE SOLUTIONS INC Insider Trading Activity - Stock Titan
BioLife Solutions (NASDAQ:BLFS) Posts Quarterly Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat
BioLife Solutions (BLFS) awards 8,170 restricted shares to director - Stock Titan
BioLife Solutions Q4 Earnings Call Highlights - Yahoo Finance
BioLife : Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations - marketscreener.com
BLFS Projects Significant Margin Expansion by 2026 - GuruFocus
BioLife Solutions (BLFS) Reports Strong Q4 Revenue and Anticipat - GuruFocus
BioLife Solutions Earnings Report: Q4 Overview - Benzinga
Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q4 Revenue $24.8M, vs. FactSet Est of $24.1M - marketscreener.com
[8-K] BIOLIFE SOLUTIONS INC Reports Material Event | BLFS SEC FilingForm 8-K - Stock Titan
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations - StreetInsider
BioLife Solutions earnings on deck as profitability tested - Investing.com India
BioLife Solutions Q4 2025 Earnings Call Transcript - MarketBeat
BioLife Solutions (BLFS) Expected to Announce Quarterly Earnings on Thursday - Defense World
What are analysts price targets for BioLife Solutions IncJuly 2025 Update & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (BLFS) Edition - Stock Traders Daily
Swing Trade: Does VANI stock reflect fundamentals2025 Breakouts & Breakdowns & Consistent Return Strategy Ideas - baoquankhu1.vn
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.58%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):